Evidence map›Paper›PMID 30008594›Full record

ArticleInternational journal of medical sciences2018

Proscillaridin A induces apoptosis, inhibits STAT3 activation and augments doxorubicin toxicity in prostate cancer cells.

Yangyang He, Muhammad Khan, Jingbo Yang, Min Yao, Shili Yu, Hongwen Gao

Open access · goldAbstract read
In one paragraph

Article in International journal of medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Bulbous PlantsPharmaceutics · 2021
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Yangyang HeDepartment of Pathology, the Second Hospital of Jilin University, Changchun 130041, P.R. China.
Muhammad KhanDepartment of Zoology, University of the Punjab, Quaid-e-Azam Campus Lahore 54590, Pakistan.
Jingbo YangJilin Provincial Key Laboratory on Molecular and Chemical Genetics, the Second Hospital of Jilin University, Changchun 130041, P.R. China.
Min YaoDepartment of Pathology, the Second Hospital of Jilin University, Changchun 130041, P.R. China.
Shili YuDepartment of Pathology, the Second Hospital of Jilin University, Changchun 130041, P.R. China.
Hongwen GaoDepartment of Pathology, the Second Hospital of Jilin University, Changchun 130041, P.R. China.
Second Affiliated Hospital of Jilin University · CNUniversity of the Punjab · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac glycosides are natural compounds used for the treatment of congestive heart failure and cardiac arrhythmias. Recently, they have been reported to exhibit anticancer activity. Proscillaridin A (PSN-A), a cardiac glycoside constituent of

Indexed as

Antibiotics, AntineoplasticApoptosisCell Line, TumorCell ProliferationDoxorubicinEnzyme InhibitorsHumansMaleProscillaridinProstatic NeoplasmsSTAT3 Transcription FactorAntibiotics, AntineoplasticDoxorubicinEnzyme InhibitorsProscillaridinSTAT3 protein, humanSTAT3 Transcription FactorBcl-2Cardiac glycosidesProscillaridin AProstate cancerSTAT3

Identifiers

PMID30008594
PMCPMC6036078
OpenAlexW2807018803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.